Actos Lawsuit News 5/3/2012: Did you take Actos? Please contact us today if you took Actos and later experienced harmful side effects. We will connect you with a lawyer that is experienced in complex litigation that may be able to help you recover monetary damages. Actos Lawsuit: The United States Food and Drug Administration issued [...]
Actos Lawsuit Information (3/26/12): Safety alerts and warnings from the U.S. Food and Drug Administration have been released regarding the possible risk of developing bladder cancer for persons who take the medication Actos for any lengthy period of time. Actos is prescribed to adults with Type II Diabetes. This drug is generating a growing number [...]
Actos Lawsuit News (3/12/12): Safety alerts and warnings from the U.S. Food and Drug Administration have been released regarding the possible risk of developing bladder cancer for persons who take the medication Actos for any lengthy period of time. Actos is prescribed to adults with Type II Diabetes. This drug is generating a growing number [...]
Actos Injury Contact Page 1-800-611-7080 Actos Injury Info (2/8/12): The diabetes medication Actos has caused some individuals harm through an Actos Injury. The FDA has an active safety alert regarding a possible Actos Injury risk to the public. According to the FDA, the side effects related to Actos Injury can be significant. As a [...]
Actos Lawsuit News – 1/26/2012: Surgery can be as effective in elderly patients as in younger patients, but it does have a higher rate of postoperative complications in older individuals who have other medical problems (commodities). Elderly people are particularly sensitive to long-term complications, lilce the metabolic disturbances that can follow urinary diversion. In those [...]
Mesothelioma Lawsuits Against Garlock May Require Immediate Action
Asbestos Campaign to Resume in UK Next Year
Mesothelioma Lawsuit Leads to $2 Million Award
Asbestos Lawsuit in Missouri Settles for $10 Million
Mesothelioma Clinical Trials: An Overview
Mesothelioma Clinical Trials Overview Series Part Two